TREATMENT WITH TAMSULOSIN IN PATIENTS WITH DISTAL URETERALCALCULI
Abstract
BACKGROUND Symptomatic ureteral calculi are one of the most important issues in urologist emergencyclinical settings. Spontaneous passage of distal ureteral calculi is usually achieved withgood hydration and spasmoanalgetic drugs. ?-blocker therapy may facilitate and accelerate the spontaneous passage of ureteral stones.Patients and In retrospective study we analyzed patients with renal colic admitted to our department inmethods 2006. All of them had clinical examination, urine and blood analysis, plain radiography(number, size and location of radiopaque calculi) and intravenous pyelography (kidneyfunction and morphology). All patients with distal ureteral calcus were treated withspasmoanalgetics and with or without ?-adrenergic antagonist tamsulosin. We analyzedeventual spontaneous passage of the calculi, additional procedures (splints, ureterorenoscopy, open procedures, extracorporeal shock wave lithotripsy (ESWL)). We used Student’st-test for statistical analysis. RESULTS 48 from 72 patients had urinary calculus. 35 (73 %) of them had calculus in the distal partof ureter. 17 (49 %) of 35 patients with distal ureteral calculus were treated with tamsulosin and in all (100 %) spontaneous stone passage was observed. 18 (51 %) patients werenot treated with tamsulosin and spontaneous passage was observed in 18 (65 %) patients(p = 0.000). CONCLUSIONS Tamsulosin therapy promotes expulsion of ureteral stonesDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
